PATENT CLAIM ANALYSIS

Application Number: 16142171
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "190100"]

Abstract:
A system and method for reducing the likelihood of colorectal cancer in a human being includes the modification of an individual's gut microbes by employing a Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated system (CRISPR-Cas) or Clustered Regularly Interspaced Short Palindromic Repeats from  Prevotella  and  Francisella  1 (CRISPR/Cpf1) system to modify only bacterial genes of bacteria that reside in the human gut that are non-homologous to those encompassed in the human genome, and in particular, to administer a therapeutically effective amount of a bacterial formulation comprising  F. prausnitzii  that has been modified to produce one of alliin or butyrate.

Claim (Index 15):
The method of  claim 1 , further comprising the modification of  H. pylori  resistance to antibiotics, including the retention and maintenance of lipid A production.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.49296
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15395419', '15392173', '16028311', '15820296', '15228454']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.717317700930157
- 35 USC 102 Novelty (BERT): 0.5793741065444113
- Combined Prediction Score: 0.7035233414915825
- Mean Citation Score: 349.762526
- Max Citation Score: 549.6457
- Similarity Product: 358.43265737543106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test